Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets. | Front Mol Biosci | 2021 | 35174209 | PubTator, text mining | PubMed |
| Hypothermia promotes synaptic plasticity and protective effects in neurological diseases. | Brain Circ | 2021 | 35071849 | PubTator, text mining | PubMed |
| Effectiveness of a Nanohydroxyapatite-Based Hydrogel on Alveolar Bone Regeneration in Post-Extraction Sockets of Dogs with Naturally Occurring Periodontitis. | Vet Sci | 2021 | 35051091 | PubTator, text mining | PubMed |
| Calcium Phosphate-Based Bioceramics in the Treatment of Osteosarcoma: Drug Delivery Composites and Magnetic Hyperthermia Agents. | Front Med Technol | 2021 | 35047940 | PubTator, text mining | PubMed |
| Biodegradable Hydrogel Scaffolds Based on 2-Hydroxyethyl Methacrylate, Gelatin, Poly(β-amino esters), and Hydroxyapatite. | Polymers (Basel) | 2021 | 35012041 | PubTator, text mining | PubMed |
| Investigations on the Influence of Collagen Type on Physicochemical Properties of PVP/PVA Composites Enriched with Hydroxyapatite Developed for Biomedical Applications. | Materials (Basel) | 2021 | 35009185 | PubTator, text mining | PubMed |
| Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational Approach. | Pharmaceuticals (Basel) | 2021 | 34959685 | PubTator, text mining | PubMed |
| Effect of Hydroxyapatite Microspheres, Amoxicillin-Hydroxyapatite and Collagen-Hydroxyapatite Composites on Human Dental Pulp-Derived Mesenchymal Stem Cells. | Materials (Basel) | 2021 | 34947112 | PubTator, text mining | PubMed |
| Influence of Natural Polysaccharides on Properties of the Biomicroconcrete-Type Bioceramics. | Materials (Basel) | 2021 | 34947091 | PubTator, text mining | PubMed |
| Atom Probe Tomography of Encapsulated Hydroxyapatite Nanoparticles. | Small Methods | 2021 | 34927889 | PubTator, text mining | PubMed |
| ER-Phagy and Microbial Infection. | Front Cell Dev Biol | 2021 | 34912806 | PubTator, text mining | PubMed |
| Polyphenols from Grape Pomace: Functionalization of Chitosan-Coated Hydroxyapatite for Modulated Swelling and Release of Polyphenols. | Langmuir | 2021 | 34905366 | PubTator, text mining | PubMed |
| Hydroxyapatite Film Coating by Er:YAG Pulsed Laser Deposition Method for the Repair of Enamel Defects. | Materials (Basel) | 2021 | 34885628 | PubTator, text mining | PubMed |
| In Vitro Dissolution of Na-Ca-P-Oxynitrides. | Materials (Basel) | 2021 | 34885580 | PubTator, text mining | PubMed |
| 3D Printed In Vitro Dentin Model to Investigate Occlusive Agents against Tooth Sensitivity. | Materials (Basel) | 2021 | 34885408 | PubTator, text mining | PubMed |
| Analysis of the Risk of Wear on Cemented and Uncemented Polyethylene Liners According to Different Variables in Hip Arthroplasty. | Materials (Basel) | 2021 | 34885400 | PubTator, text mining | PubMed |
| Influence of Culture Period on Osteoblast Differentiation of Tissue-Engineered Bone Constructed by Apatite-Fiber Scaffolds Using Radial-Flow Bioreactor. | Int J Mol Sci | 2021 | 34884885 | PubTator, text mining | PubMed |
| Quantitative Proteomics and Differential Protein Abundance Analysis after the Depletion of PEX3 from Human Cells Identifies Additional Aspects of Protein Targeting to the ER. | Int J Mol Sci | 2021 | 34884833 | PubTator, text mining | PubMed |
| Efficacy for Whitlockite for Augmenting Spinal Fusion. | Int J Mol Sci | 2021 | 34884680 | PubTator, text mining | PubMed |
| Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma. | Proc Natl Acad Sci U S A | 2021 | 34873045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=28